ChromaDex Corp. (CDXC)

[Milarepa]

I have seen RLS and IBS stories, but not hair regrowth. The photos in the article you linked aren't obvious to me, but maybe.

My assumption on the share price is that it is being driven by shorts who are attuned to a high multiple of revenue (10x last June, 4x now) and an infinitely high multiple of EBITDA. Worst case is they know something we don't. I mean, if NR turns out to be dangerous, ineffective, or easily substitutable, then the stock's value will not go back up.

But my feeling is that they are wrong, and we are lucky that it stays low, because we longs get to tank up every week with our left-over lunch money, and bring down our average share cost. I'm not in a rush.

I do not think the Investor Relations people are doing anything wrong -- the company is executing a smart plan, and I'm glad I'm not short against it. However, nothing but human research is going to resolve the doubt, and there's loads of research coming, although word-of-mouth success stories will help in the meantime.

My biggest concern is that people will grab onto studies like the one I mentioned earlier where they feed NR to young rats, with no evidence of NAD+ depletion, and then observe no positive effect. How could there be a positive effect? Giving NR to kids is probably like giving water to a fish.

Elysium continues to advertise like crazy, so I assume they are continuing to get good results from their ads.